Infant Bacterial Therapeutics AB (publ) (IBT-B.ST)

Home
IBT-B.ST
Financials

93.4 (SEK) • At close February 20, 2024

Overview | Financials

Numbers are in millions (except for per share data and ratios) SEK.

	2024 Q2	2024 Q1	2023 Q4	2023 Q3	2023 Q2	2023 Q1	2022 Q4	2022 Q3	2022 Q2	2022 Q1	2021 Q4	2021 Q3	2021 Q2	2021 Q1	2020 Q4	2020 Q3	2020 Q2	2020 Q1	2019 Q4	2019 Q3	2019 Q2	2019 Q1	2018 Q4	2018 Q3	2018 Q2	2018 Q1	2017 Q4	2017 Q3	2017 Q2	2017 Q1	2016 Q4	2016 Q3	2016 Q2	2016 Q1	2015 Q4	2015 Q3	2015 Q2	2015 Q1
Revenue Numbers are in millions	0	0.005	0	0.064	0	0.013	0.009	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.121	0.117	0.113	0.049	0	0	0	0	0	0
Cost of Revenue Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Gross Profit Numbers are in millions	0	0.005	0	0.064	0	0.013	0.009	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.121	0.117	0.113	0.049	0	0	0	0	0	0
Gross Profit Ratio Numbers are in millions	0	1	0	1	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	1	1	0	0	0	0	0	0
Reseach & Development Expenses Numbers are in millions	36.685	27.892	47.882	31.068	30.09	21.53	40.766	7.746	-1.758	19.066	16.093	-0.228	29.195	-0.388	26.703	18.665	27.994	-1.131	27.426	11.007	7.923	0.929	23.876	7.683	-1.286	9.144	9.059	4.571	13.947	8.68	14.225	10.492	10.975	5.103	4.151	4.151	4.837	4.837
General & Administrative Expenses Numbers are in millions	7.594	1.91	7.157	2.714	0.862	2.779	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.246	0.246	0	0
Selling & Marketing Expenses Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.543	0	0	1.3	1.3	0	0
SG&A Numbers are in millions	7.594	1.91	7.157	2.714	0.862	2.779	1.017	0	0	0	1.115	0	0	0	1.136	0	0	0	1.235	0	0	0	1.086	0	0	0	0.957	0	0	0	0.834	2.543	0	0	1.546	1.546	0	0
Other Expenses Numbers are in millions	0	0	0	0	0	-0.013	-0.009	0	0	-0.003	0	0	-0.031	-0.064	-0.079	-0.079	-0.079	-0.075	0	0	0	0	0	0	0	0	0	0	0	0	0	-2.543	0	0	0	0	0	0
Operating Expenses Numbers are in millions	44.279	29.797	55.039	33.718	30.952	24.296	40.757	7.746	-1.758	19.063	16.093	-0.228	29.164	-0.452	26.624	18.586	27.915	-1.206	27.426	11.007	7.923	0.929	23.876	7.683	-1.286	9.144	9.059	4.571	13.947	8.68	14.225	7.949	10.975	5.103	4.83	4.83	4.837	4.837
Operating Income Numbers are in millions	-44.279	-29.798	-55.039	-33.718	-30.952	-24.296	-40.757	-7.746	1.758	-19.063	-16.093	0.228	-29.164	0.452	-26.624	-18.586	-27.915	1.206	-27.426	-11.007	-7.923	-0.929	-23.876	-7.683	1.286	-9.144	-9.059	-4.571	-13.826	-8.563	-14.112	-7.9	-10.975	-5.103	-5.471	-5.471	-4.837	-4.837
Operating Income Ratio Numbers are in millions	0	-5,959.6	0	-526.844	0	-1,868.923	-4,528.556	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-114.264	-73.188	-124.885	-161.224	0	0	0	0	0	0
Total Other Income Expenses Net Numbers are in millions	1.604	1.984	4.759	2.829	2.132	1.827	0.641	-0.036	-0.11	-0.138	-0.125	-0.286	-0.001	-0.001	-0.024	-0.014	-0.022	-0.028	-0.108	0.469	0.362	0.243	-0.267	-0.302	-0.621	0	0	-0.015	-0.001	0	0.007	0.183	0	-0.062	10.3	10.3	-0.004	-0.004
Income Before Tax Numbers are in millions	-42.675	-27.814	-40.891	-30.889	-28.82	-22.469	-40.116	-7.782	1.648	-19.201	-16.218	-0.058	-29.165	0.451	-26.648	-18.6	-27.937	1.178	-27.534	-10.538	-7.561	-0.686	-24.143	-7.985	0.665	-9.144	-9.059	-4.586	-13.827	-8.563	-14.105	-7.717	-10.975	-5.165	4.829	4.829	-4.84	-4.84
Income Before Tax Ratio Numbers are in millions	0	-5,562.8	0	-482.641	0	-1,728.385	-4,457.333	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-114.273	-73.188	-124.823	-157.49	0	0	0	0	0	0
Income Tax Expense Numbers are in millions	0	1.985	-0.204	2.828	2.132	-0.001	-0.641	0.036	0.11	0.138	0.125	0	0	0	0.041	0.058	0.058	0.058	0.026	0.638	0.546	0.481	0.157	0.17	0	0	0	0	0	0	0	-7.9	-10.975	-0.062	10.3	10.3	-0.004	-0.004
Net Income Numbers are in millions	-42.675	-27.815	-40.891	-30.888	-28.82	-22.468	-39.475	-7.818	1.648	-19.339	-16.218	-0.058	-29.165	0.451	-26.648	-18.6	-27.937	1.178	-27.534	-10.538	-7.561	-0.686	-24.143	-7.985	0.665	-9.144	-9.059	-4.586	-13.827	-8.563	-14.105	-7.717	-10.975	-5.165	4.829	4.829	-4.84	-4.84
Net Income Ratio Numbers are in millions	0	-5,563	0	-482.625	0	-1,728.308	-4,386.111	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-114.273	-73.188	-124.823	-157.49	0	0	0	0	0	0
EPS Numbers are in millions	-3.17	-2.06	-3.04	-2.31	-2.57	-2	-3.52	-0.7	0.15	-1.72	-1.44	-0.005	-2.6	0.04	-2.37	-1.66	-2.49	0.1	-2.45	-0.94	-0.67	-0.061	-2.15	-0.71	0.059	-0.96	-1.54	-0.78	-2.51	-1.56	-2.3	-1.25	-2.51	-2.82	2.66	2.66	-2.7	-2.7
EPS Diluted Numbers are in millions	-3.17	-2.06	-3.04	-2.31	-2.57	-2	-3.52	-0.7	0.15	-1.72	-1.44	-0.005	-2.6	0.04	-2.37	-1.66	-2.49	0.1	-2.45	-0.94	-0.67	-0.061	-2.15	-0.71	0.059	-0.96	-1.47	-0.78	-2.51	-1.56	-2.29	-1.25	-2.51	-2.82	2.66	2.66	-2.7	-2.7
EBITDA Numbers are in millions	-42.471	-27.61	-40.891	-30.685	-28.616	-22.265	-39.903	-7.542	0	-18.859	-15.889	0	-28.96	0.656	-26.379	-18.324	-27.653	1.468	-27.33	-10.165	-7.173	-0.244	-23.939	-7.781	1.49	-8.94	-8.855	-4.367	-13.622	-8.359	-13.301	0	0	0	0	0	0	0
EBITDA Ratio Numbers are in millions	0	-5,522	0	-479.453	0	-1,712.692	-4,433.667	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-112.579	-71.444	-117.708	-161.224	0	0	0	0	0	0

Infant Bacterial Therapeutics AB (publ)

SSE:IBT-B.ST Add to watchlist

SSE:IBT-B.ST